Literature DB >> 8139659

The human X-inactivation centre is not required for maintenance of X-chromosome inactivation.

C J Brown1, H F Willard.   

Abstract

X-chromosome inactivation occurs early in mammalian female development to achieve dosage compensation with males. Although it is widely accepted that this inactivation requires the presence in cis of the X-inactivation centre (XIC), it is not known whether the XIC is required for the initiation, promulgation or maintenance of X inactivation. The XIST gene, which is localized within the XIC interval on both the human and mouse X chromosomes, is constitutively expressed from inactive X chromosomes, suggesting a possible role in the maintenance of X inactivation. To address whether the presence of the XIC, including the XIST gene, is continuously required for the maintenance of X-chromosome inactivation, we have analysed the transcriptional activity of a number of X-linked genes in mouse/human somatic cell hybrids retaining an intact human inactive X chromosome or derivatives of the inactive X chromosome lacking the XIC. Genes subject to X inactivation remain transcriptionally silent despite the loss of the XIC, demonstrating that the presence of the XIC is not required for the maintenance of X inactivation in somatic cells.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8139659     DOI: 10.1038/368154a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  93 in total

1.  Histone variant macroH2A contains two distinct macrochromatin domains capable of directing macroH2A to the inactive X chromosome.

Authors:  B P Chadwick; C M Valley; H F Willard
Journal:  Nucleic Acids Res       Date:  2001-07-01       Impact factor: 16.971

2.  A Functional chromatin domain does not resist X chromosome inactivation: silencing of cLys correlates with methylation of a dual promoter-replication origin.

Authors:  Suyinn Chong; Joanna Kontaraki; Constanze Bonifer; Arthur D Riggs
Journal:  Mol Cell Biol       Date:  2002-07       Impact factor: 4.272

Review 3.  Heterochromatin instability in cancer: from the Barr body to satellites and the nuclear periphery.

Authors:  Dawn M Carone; Jeanne B Lawrence
Journal:  Semin Cancer Biol       Date:  2012-06-18       Impact factor: 15.707

4.  Derivation conditions impact X-inactivation status in female human induced pluripotent stem cells.

Authors:  Kiichiro Tomoda; Kazutoshi Takahashi; Karen Leung; Aki Okada; Megumi Narita; N Alice Yamada; Kirsten E Eilertson; Peter Tsang; Shiro Baba; Mark P White; Salma Sami; Deepak Srivastava; Bruce R Conklin; Barbara Panning; Shinya Yamanaka
Journal:  Cell Stem Cell       Date:  2012-07-06       Impact factor: 24.633

5.  X inactivation in human testicular tumors. XIST expression and androgen receptor methylation status.

Authors:  L H Looijenga; A J Gillis; R J van Gurp; A J Verkerk; J W Oosterhuis
Journal:  Am J Pathol       Date:  1997-08       Impact factor: 4.307

Review 6.  X-chromosome inactivation and escape.

Authors:  Christine M Disteche; Joel B Berletch
Journal:  J Genet       Date:  2015-12       Impact factor: 1.166

7.  BRCA1 associates with the inactive X chromosome in late S-phase, coupled with transient H2AX phosphorylation.

Authors:  Brian P Chadwick; Timothy F Lane
Journal:  Chromosoma       Date:  2005-11-15       Impact factor: 4.316

8.  Hematopoietic precursor cells transiently reestablish permissiveness for X inactivation.

Authors:  Fabio Savarese; Katja Flahndorfer; Rudolf Jaenisch; Meinrad Busslinger; Anton Wutz
Journal:  Mol Cell Biol       Date:  2006-10       Impact factor: 4.272

9.  Multiple spatially distinct types of facultative heterochromatin on the human inactive X chromosome.

Authors:  Brian P Chadwick; Huntington F Willard
Journal:  Proc Natl Acad Sci U S A       Date:  2004-12-01       Impact factor: 11.205

10.  Mcm1 regulates donor preference controlled by the recombination enhancer in Saccharomyces mating-type switching.

Authors:  C Wu; K Weiss; C Yang; M A Harris; B K Tye; C S Newlon; R T Simpson; J E Haber
Journal:  Genes Dev       Date:  1998-06-01       Impact factor: 11.361

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.